• Mashup Score: 0
    Top news of July: OSA combination drug, COVID-19 diaphragm muscle weakness - 9 month(s) ago

    Healio has compiled the most-read news in pulmonology posted in July.Highlights include a study showing reduced obstructive sleep apnea severity with a combination of atomoxetine and oxybutynin taken for 1 month; a link between diaphragm muscle weakness and shortness of breath after COVID-19; declining cognition in older adults with OSA; men with HIV more frequently having sleep-disordered

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      Healio Pulmonology's most-read news story from July was on a study showing reduced obstructive sleep apnea (#OSA) severity with a combination drug taken for 1 month. Click the link below to read this story and more top stories from July! https://t.co/I3tUUNBBRN

  • Mashup Score: 0
    Severe obstructive sleep apnea lessens esketamine effects in veterans with PTSD - 10 month(s) ago

    WASHINGTON — Veterans taking esketamine for PTSD had less improvement in symptoms when they had high obstructive sleep apnea severity at baseline, according to an abstract presented at the American Thoracic Society International Conference.“Our findings suggest that untreated obstructive sleep apnea (OSA) may interfere with effective esketamine treatment on PTSD symptoms,”

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      #ATS2023: When factoring in a patient’s baseline apnea-hypopnea index score, those with scores that indicated greater #OSA severity demonstrated fewer changes in #PTSD Checklist for DSM-5 scores over the increasing number of #esketamine doses. https://t.co/uRynOYWmky

  • Mashup Score: 0
    ‘High efficacy’ with mandibular advancement device in new moderate to severe OSA - 11 month(s) ago

    WASHINGTON — For patients with new moderate to severe obstructive sleep apnea, mandibular advancement device therapy reduced disorder severity, according to an abstract presented at the American Thoracic Society International Conference.“Continuous positive airway pressure (CPAP) is often recommended as first-line treatment option for patients with moderate to severe obstructive sleep

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      Presented at #ATS2023: For patients with new moderate to severe obstructive sleep apnea (#OSA), mandibular advancement device therapy reduced disorder severity. @atscommunity https://t.co/9pko0V9brb

  • Mashup Score: 0
    CPAP improves cognition in patients with Parkinson’s disease, obstructive sleep apnea - 11 month(s) ago

    WASHINGTON — Among patients with Parkinson’s disease, obstructive sleep apnea and decreased cognition, CPAP therapy improved cognitive function, according to an abstract presented at the American Thoracic Society International Conference.“Our results show that most patients can use CPAP to some extent and that cognitive benefits can be derived even from use for under 4 hours per

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      ICYMI: Patients with Parkinson’s disease, obstructive sleep apnea (#OSA) and decreased cognition treated with #CPAP had improved cognitive function, according to an abstract presented at #ATS2023. https://t.co/QqyN2hxCiR

  • Mashup Score: 0
    First UK hypoglossal nerve stimulation implant in the treatment for moderate to severe OSA - 11 month(s) ago

    Obstructive sleep apnoea has been treated in many different ways over the years. We hear from Yakubu Karagama about one of the latest surgical developments. Introduction Obstructive sleep apnoea (OSA) is by far the most common sleep disorder, affecting all ages and sexes. OSA is defined as a repeated obstruction of the upper airway during sleep. It is diagnosed through patient history,…

    Source: ENT & Audiology News
    Categories: Latest Headlines, Otolaryngology
    Tweet Tweets with this article
    • Profile photo of ENT_AudsNews
      ENT_AudsNews

      The first-ever hypoglossal nerve stimulation implant in the UK for treating moderate to severe #OSA is making waves! Discover the groundbreaking surgical development and gain insights from @EntKaragama in our latest article. 👇Read more: https://t.co/NNI3RLy1vI #ENTAuds

  • Mashup Score: 0
    Top news of May: Obstructive sleep apnea drug combination, central sleep apnea mortality - 11 month(s) ago

    Healio has compiled the most-read news in pulmonology posted in May.Highlights include an oral drug combination that lowered obstructive sleep apnea severity; worse mortality outcomes found in veterans with central sleep apnea vs. OSA; ensifentrine found to improve measures of lung function, quality of life and exacerbations in patients with COPD; decreased prevalence of cigarette smoking in

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      Healio Pulmonology's most-read news story from May was on an oral drug combination that lowered obstructive sleep apnea (#OSA) severity. Click the link below to read this story and more top stories from May. https://t.co/neWDNU0TQO

  • Mashup Score: 0
    High likelihood for OSA, depression, poor asthma control in patients with asthma, insomnia - 11 month(s) ago

    WASHINGTON — More patients with asthma and insomnia had obstructive sleep apnea, depression and worse exacerbations than patients without insomnia, according to research presented at the American Thoracic Society International Conference.“I hope these findings raise awareness among providers that patients with asthma may have poor nocturnal control, or poor disease control in general,

    Source: www.healio.com
    Categories: Latest Headlines, Pulmonology
    Tweet Tweets with this article
    • Profile photo of HealioPulm
      HealioPulm

      Presented at #ATS2023: More patients with #asthma and insomnia had obstructive sleep apnea (#OSA), depression and worse #exacerbations than patients without insomnia. @HealioAllergy @HealioPsych @atscommunity https://t.co/wexVe2sATD

  • Mashup Score: 0
    Which Drug Best Reduces Sleepiness in Patients With OSA? - 12 month(s) ago

    A systematic review indicates that solriamfetol (Sunosi) is likely superior to other wake-promoting agents in reducing excessive daytime sleepiness in patients with obstructive sleep apnea.

    Source: Medscape
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Medscape
      Medscape

      Solriamfetol is probably more effective than other wakefulness-promoting medications in patients with #OSA who have residual daytime sleepiness after conventional treatment, according to a systematic review and meta-analysis. #sleepapnea https://t.co/zxCJmVgxOz

Load More